Free 7-day Trial
All Articles and Columns »

Synta Pharmaceuticals Inc. (SNTA) CEO Safi R Bahcall buys 5,000 Shares

March 15, 2011 | About:
10qk

insider

56 followers
President and CEO of Synta Pharmaceuticals Inc. (SNTA) Safi R Bahcall buys 5,000 shares of SNTA on 03/15/2011 at an average price of $4.45 a share.

Synta Pharmaceuticals Corp. has a market cap of $189 million; its shares were traded at around $4.5 with and P/S ratio of 1.3.

CFO Recent Trades:



  • Sell: VP, Fin. and Admin., CFO Keith S Ehrlich sold 2,537 shares of SNTA stock on 03/01/2011 at the average price of 5.51. Keith S Ehrlich owns at least 21,970 shares after this. The price of the stock has decreased by 18.33% since.

This is the insider trade history vs. stock price of SNTA. For the complete insider trading history of SNTA, click here.




Directors and Officers Recent Trades:



  • Sell: SVP, Chief Medical Officer Vojo Vukovic sold 2,617 shares of SNTA stock on 03/01/2011 at the average price of 5.32. Vojo Vukovic owns at least 22,304 shares after this. The price of the stock has decreased by 15.41% since.
  • Sell: VP, IP and Legal, Gen. Counsel Wendy E Rieder sold 5,284 shares of SNTA stock on 03/01/2011 at the average price of 5.25. Wendy E Rieder owns at least 19,823 shares after this. The price of the stock has decreased by 14.29% since.
  • Sell: Sr. VP, Drug Development Keizo Koya sold 18,270 shares of SNTA stock on 03/01/2011 at the average price of 5.23. Keizo Koya owns at least 39,843 shares after this. The price of the stock has decreased by 13.96% since.


For the complete insider trading history of SNTA, click here.

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 3.8/5 (4 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide